Clinical Trial Update: Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer [NA]

View source ↗

Summary

A study evaluating zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for prostate cancer has completed. The update does not pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Prostatic Neoplasms, Bone Density | NA | Status: COMPLETED